Journal Browser
Volume | Year
News and Announcements
View All
Aims & Scope

Cancer Plus is a research journal that aims to provide a peer-reviewed, open access platform for researchers and practitioners to present novel and high-impact articles in the field of cancer research and clinical trials. This journal is a collaboration between the Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital (China), and the Chinese Academy of Sciences. Areas of interest for this journal include, but are not limited to, the following topics:

  • Mechanisms of tumorigenesis
  • Genetic alterations of cancer
  • Epigenetics of cancer
  • Cell signalling
  • Cancer stem cells
  • Cancer prevention
  • Diagnosis 
  • Cancer drugs/chemotherapy/therapeutic methods
  • Clinical trials
Cancer Plus accepts a range of submissions (please read the Author's Guidelines for more details):
  • Research Articles
  • Review Articles
  • Perspective Articles
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Case Reports
Back to top
Cancer Plus, Electronic ISSN: 2661-3840 Print ISSN: 2661-3832, Published by AccScience Publishing